news
Nanoparticles useful in treating venomous snakebites
In the future, venomous snakebites could be treated using nanoparticles to bind the venom toxins and prevent them from spreading around the body...
List view / Grid view
Drug delivery
news
The new standard foldable IBC for international logistics
Schoeller Allibert’s new standard foldable intermediate bulk container (IBC) is designed for international logistics. The Combo Excelsior® was created to meet the latest expectations of the food processing, cosmetics and pharmaceutical industries. Safe, hygienic and efficient, it offers the best logistics solution on the market for maximised profitability...
news
Direct eye injections best treat uveitic macular edema: study
Direct eye injections treat uveitic macular edema more effectively than treatments placed adjacent to the eye, reveals new Mount Sinai research...
news
Are tiny, soft robots the future of drug delivery?
Researchers have developed a tiny, soft drug delivery robot with multiple legs, which is capable of handling and carrying heavy loads...
news
Inhaler delivers cannabinoids faster at lower doses
Researchers have released data on a clinical trial using specific inhalers and oral capsules to deliver cannabinoids to participants...
news
Aluminium could aid delivery of chemotherapy drugs
Aluminium could be key for the effective and efficient adsorption of chemotherapy drugs for targeted delivery and reduced side effects...
news
Smart pills could ‘dumb down’ medical care
Research suggest that the use of smart pills should be only after carefully evaluating their clinical efficacy against standard of care drugs...
webinar
Understanding the complexities of global serialisation & traceability regulations
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
news
Inhaled blood pressure drug shows promise in treating anxiety and pain
The inhaled version of a high blood pressure drug may treat some types of anxiety and pain, reveals new research from the Centre for Addiction and Mental Health...
news
Medical cannabis effective in treating wide range of health conditions
Medical cannabis has shown to decrease symptoms in a variety of health conditions, including chronic pain and insomnia...
news
HD vein imaging aids intravenous injections
Near-infrared light can now be used to aid clinicians in identifying veins in patients, especially when this process becomes difficult...
news
NHS announces groundbreaking personalised child cancer treatment
The NHS has announced a groundbreaking new treatment, CAR-T, for children with leukaemia...
news
New programme increases use of HIV medication in injection-drug users
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...
news
Seizures could be stopped and prevented with implanted electronic device
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
article
Issue 4, 2018
A US perspective on how pharma companies are preparing for Brexit, overcoming disinfectant residues with culture media neutralisers, unlocking the potential of new technology in biopharma, and much more in this issue of European Pharmaceutical Review.
